Company Profile

Third Eye Diagnostics Inc
Profile last edited on: 6/27/19      CAGE: 4XJR4      UEI:

Business Identifier: Non-invasive intracranial pressure monitor
Year Founded
2007
First Award
2009
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

116 Research Drive
Bethlehem, PA 18015
   (650) 678-4101
   info@3-e-d.com
   www.3-e-d.com
Location: Single
Congr. District: 07
County: Northampton

Public Profile

Third Eye Diagnostics is a medical device company developing diagnostic tools using ophthalmic technologies. Addressing the unmet need for non-invasively diagnosing elevated intracranial pressure the firm's developed device is a non-invasive intracranial pressure monitor that is designed to be used by physicians in the diagnosis and treatment of head injury. Patients with head injury, hemorrhage, or stroke require monitoring of intracranial pressure. Withe NSF SBIR support, the firm undertook the prototype development and clinical studies that preceded commercialization of their device - designated Cerepress, a non-invasive intracranial pressure (ICP) monitor. The monitor gathers pressure measurements externally from the eye of patients with a head injury or who have suffered a stroke. Existing standard-of-care devices that monitor ICP are invasive and require drilling a hole through the patient’s skull to measure pressure potentially exposing patients to significant complications, and posing a significant and preventable cost. Third Eye's product represented a first-of-its-kind non-invasive intracranial pressure monitor gathering information from the patient's eye. The technology was based on one issued patent, one pending patent, and two applications in progress atthe timeof award on methods and apparatus that correlate ICP with measurements taken from the blood vessels within the eye. The Cerepress™ measures blood pressure in the eye’s central retinal vein (CRV) which highly correlates to intracranial pressure. 2019: Present status of firm and the project is not c

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 2 NSF $1,028,756
Project Title: Non-Invasive Intracranial Pressure Monitor
2013 2 NSF $650,000
Project Title: Non-invasive Intracranial Pressure Monitor

Key People / Management

  Terry A Fuller -- Chief Executive Officer

  Anthony Bellezza -- Chief Operating Officer

  Mark Dorfman -- Chief Financial Officer

  William Lai -- VP of Biomedical Engineering

  Vinod Vijayakumar -- Director of Clinical and Regulatory Affairs